K. Matsumura

Genetically-Based Olfactory Signatures Persist Despite Dietary Variation

Alan Willse, Gary K. Beauchamp, George Preti, 2008, PloS one.

Indirect analysis of first-line therapy for advanced non-small-cell lung cancer with activating mutations in the Japanese population.

K. Wilner, K. Nakagawa, K. Matsumura, 2020, Future oncology.

Real-World Evidence of Diagnostic Testing for Driver Oncogene Mutations in Lung Cancer in Japan

Y. Yatabe, K. Nishio, K. Togo, 2020, JTO clinical and research reports.

Urinary Volatile Compounds as Biomarkers for Lung Cancer: A Proof of Principle Study Using Odor Signatures in Mouse Models of Lung Cancer

H. Oka, G. Beauchamp, S. Albelda, 2010, PloS one.

Major histocompatibility complex-regulated odortypes: Peptide-free urinary volatile signals

G. Preti, G. Beauchamp, K. Yamazaki, 2009, Physiology & Behavior.

Urinary Volatile Compounds as Biomarkers for Lung Cancer

Anil Vachani, Hiroaki Oka, Yosuke Hanai, 2012, Bioscience, biotechnology, and biochemistry.

P69.01 Real-World Data of EGFR-TKI Treatment Sequence in Non-Small Cell Lung Cancer Patients in Japan

H. Kenmotsu, K. Ito, K. Togo, 2021 .